Mode
Text Size
Log in / Sign up
N/A N=7 Supportive Care

Palliative Care for Persons With ADRD and CI in SNF

Advance Care Planning · Palliative Care · Skilled Nursing Facility · Cognitive Impairment

Enrolled (actual)
7
Serious AEs
Results posted
Aug 2024
Primary outcome: Primary: Number of Participants That Completed Patient Quality of Life Survey — 4; 3; 3; 3 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Palliative Care Consultation (Other)
Age
Adult, Older Adult · 60+ yrs
Sex
All
Sponsor
University of Maryland, Baltimore
Primary completion
Apr 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants That Completed Patient Quality of Life Survey
4; 3; 3; 3
SECONDARY
Number of Participants That Completed Satisfaction With Care Survey (SWC-EOLD)
4; 3; 3; 3
SECONDARY
Number of Participants That Completed the Symptom Management Survey (SM-EOLD)
4; 3; 3; 3

Summary

Alzheimer's disease and related dementias (ADRD) are serious, life limiting illnesses with no known cure. Dementia is the fifth-leading cause of death in older adults and the majority of people with advanced dementia die in nursing homes (NHs). Miller et al reported that 40% of U.S. NH residents dying with advanced dementia received Skilled Nursing Facility (SNF) care in the last 90 days of life, and receipt of this care was associated significantly with poorer end-of-life outcomes, including a higher risk of dying in a hospital, compared to decedents with no SNF care. SNF care is a Medicare post-acute rehabilitation service delivered in NHs focused on intense rehabilitation and/or aggressive, disease-modifying therapies. Regardless of life expectancy, use of SNF care precludes access to Hospice services. Palliative care (PC) offers an evidence-based alternative.

Eligibility Criteria

KEY INCLUSION CRITERIA

Patients:

  • Admitted for SNF post-acute care at a participating NHs following a recent hospitalization
  • Age ≥ 60 years old
  • Speaks English (if verbal)
  • If non-verbal/unable to participate in a conversation and/or unable to make decisions, a legally authorized representative (LAR)/surrogate decision maker who can make decisions for the patient as determined by ACTs staff
  • Documented ADRD diagnosis in the medical record or history of cognitive impairment (defined as BIMS score ≤ 12)
  • At least one global indicator for PC at SNF admission (provider would not be surprised if patient died within 1 year, believes the patient would benefit from advance care planning or symptom management; frequent hospital or NH SNF admissions; complex care requirements; decline in function; feeding intolerance; unintended decline in weight; or previous hospice assessment or enrollment and subsequent discharge)

Surrogate/LAR:

  • ≥18 years old
  • Family member or friend of an eligible patient as determined by ACTs staff
  • Speaks English

KEY EXCLUSION CRITERIA

Patients:

  • Who have previously received or are referred for PC by their primary care team
  • With a discharge plan within 48 hours of screening
  • Currently receiving hospice care
  • Who do not have one global indicator of need
  • No documented ADRD diagnosis or history of cognitive impairment in the medical record
  • That are non-English speaking, (if verbal)
  • If unable to make decisions, do not have an LAR/surrogate decision maker.

Surrogate/LAR:

  • < 18 years of age
  • Not a family Member or friend of an eligible patient
  • Non-English speaking
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05308004). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search